Comparison of BuMA eG Based BioDegradable Polymer Stent With EXCEL Biodegradable Polymer Sirolimus-eluting Stent in Real-World Practice
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2348 participants.
Also called NCT02017275
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 2,348 participants
- Registry
-
NCT02017275
-
- Other papers using this trial's data
- Biodegradable Polymer-Based Sirolimus-Eluting Stents With Differing Elution and Absorption Kinetics: The PANDA III Trial
- Outcomes of quantitative flow ratio-based percutaneous coronary intervention in an all-comers study
- [Prognostic value of SYNTAX score on 1 year outcome in patients underwent percutaneous coronary intervention]
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- Not reported
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT02017275. Randomized; single masking; primary purpose treatment. Start 2013-11 (registry gives no type); primary completion 2015-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of BuMA eG Based BioDegradable Polymer Stent With EXCEL Biodegradable Polymer Sirolimus-eluting Stent in "Real-World" Practice
- Acronym
- PANDA-III
- Condition
- Coronary Artery Disease
- Intervention (Device)
- BuMA
- Intervention (Device)
- EXCEL
- Lead sponsor
- Sino Medical Sciences Technology Inc.
Record details
- Record id
cardio:ct-nct02017275- Content hash
10e084f197715299621d820c9c836f110150774eaa2d28720a997b4e946f7406